Identification of Escherichia coli enterotoxin inhibitors from traditional medicinal herbs by in silico, in vitro, and in vivo analyses

Journal of Ethnopharmacology

Volumn 121, Issue 3, 2009, Pages 372-378

  Chen, Jaw Chyun ^a   Ho, Tin Yun ^a   Chang, Yuan Shiun ^a   Wu, Shih Lu ^a   Li, Chia Cheng ^a   Hsiang, Chien Yun ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Docking analysis; GM1; Glycyrrhizin; Heat labile enterotoxin

Indexed keywords

ALISMA ORIENTALIS EXTRACT; ALPHA HEDERIN; ANGELICA SINENSIS EXTRACT; BETA AMYRIN; BUPLEURUM CHINENSE EXTRACT; CINNAMOMON CASSIA EXTRACT; COPTIS CHINENSIS EXTRACT; ESCHERICHIA COLI ENTEROTOXIN; EUGENIA CARYOPHYLLATA EXTRACT; FRIEDELIN; GANGLIOSIDE GM1; GINSENG EXTRACT; GLYCYRRHIZA URALENSIS EXTRACT; GLYCYRRHIZIC ACID; MAGNOLIAE OFFICINALIS EXTRACT; NELUMBO NUCIFERA EXTRACT; PLANT EXTRACT; SAIKOSAPONIN A; TRITERPENOID; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ALISMA ORIENTALIS; ANGELICA SINENSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BUPLEURUM CHINENSE; CINNAMOMON CASSIA; CLOVE; COMPUTER MODEL; COPTIS CHINENSIS; DIARRHEA; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINSENG; GLYCYRRHIZA URALENSIS; HERB; IC 50; IN VITRO STUDY; IN VIVO STUDY; MAGNOLIAE OFFICINALIS; MOUSE; NELUMBO NUCIFERA; NONHUMAN; PROTEIN PROTEIN INTERACTION; STRUCTURE ANALYSIS; TRADITIONAL MEDICINE;

ANIMALS; ANTI-BACTERIAL AGENTS; DIARRHEA; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXINS; ESCHERICHIA COLI INFECTIONS; FEMALE; GANGLIOSIDES; GLYCYRRHIZA URALENSIS; GLYCYRRHIZIC ACID; MICE; MICE, INBRED BALB C; OLEANOLIC ACID; PHYTOTHERAPY; PLANT EXTRACTS; VIRULENCE FACTORS;

ESCHERICHIA COLI; GLYCYRRHIZA URALENSIS; MUS;

EID: 58149236548     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.11.011     Document Type: Article

References (40)

1. Ahlquist D.A., and Camilleri M. Diarrhea and constipation. In: Braunwald E., Fauci A.S., Kasper D.L., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's Principles of Internal Medicine. 15th ed. (2001) 241-250
2. Aranda-Michel J., and Giannella R.A. Acute diarrhea: a practical review. The American Journal of Medicine 106 (1999) 670-676
3. Baselski V., Briggs R., and Parker C. Intestinal fluid accumulation induced by oral challenge with Vibrio cholerae or cholera toxin in infant mice. Infection and Immunity 15 (1997) 704-712
4. Blumenthal M., Goldberg A., Brinckmann J., and Foster S. Herbal Medicine-Expanded Commission E Monographs (2000), American Botanical Council, Austin, TX pp. 233-239
5. Bruins M.J., Cermak R., Kiers J.L., van der Meulen J., van Amelsvoort J.M.M., and van Klinken B.J.W. In vivo and in vitro effects of tea extracts on enterotoxigenic Escherichia coli-induced intestinal fluid loss in animal models. Journal of Pediatric Gastroenterology and Nutrition 43 (2006) 459-469
6. Chang D.T., Oyang Y.J., and Lin J.H. MEDock: a web server for efficient prediction of ligand binding sites based on a novel optimization algorithm. Nucleic Acids Research 33 (2005) W233-W238
7. Chen J.C., Chang Y.S., Wu S.L., Chao D.C., Chang C.S., Li C.C., Ho T.Y., and Hsiang C.Y. Inhibition of Escherichia coli heat-labile enterotoxin-induced diarrhea by Chaenomeles speciosa. Journal of Ethnopharmacology 113 (2007) 233-239
8. Chen J.C., Huang L.J., Wu S.L., Kuo S.C., Ho T.Y., and Hsiang C.Y. Ginger and its bioactive component inhibit enterotoxigenic Escherichia coli heat-labile enterotoxin-induced diarrhea in mice. Journal of Agricultural and Food Chemistry 55 (2007) 8390-8397
9. Chen J.C., Ho T.Y., Chang Y.S., Wu S.L., and Hsiang C.Y. Anti-diarrheal effect of Galla Chinensis on the Escherichia coli heat-labile enterotoxin and ganglioside interaction. Journal of Ethnopharmacology 103 (2006) 385-391
10. Chitme H.R., Chandra R., and Kaushik S. Studies on anti-diarrheal activity of calotropis gigantean R.BR. in experimental animals. Journal of Pharmacy and Pharmaceutical Sciences 7 (2004) 70-75
11. Dolinsky T.J., Nielsen J.E., McCammon J.A., and Baker N.A. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Research 32 (2004) W665-W667
12. Fan E., Merritt E.A., Zhang Z., Pickens J.C., Roach C., Ahn M., and Hol W.G. Exploration of the GM1 receptor-binding site of heat-labile enterotoxin and cholera toxin by phenyl-ring-containing galactose derivatives. Acta Crystallographica, Section D 57 (2001) 201-212
13. Field M. Intestinal ion transport and the pathophysiology of diarrhea. The Journal of Clinical Investigation 111 (2003) 931-943
14. Fiore C., Eisenhut M., Ragazzi E., Zanchin G., and Armanini D. A history of the therapeutic use of liquorice in Europe. Journal of Ethnopharmacology 99 (2005) 317-324
15. Garg P., Chakraborty S., Basu I., Datta S., Rajendran K., Bhattacharya T., Yamasaki S., Bhattacharya S.K., Takeda Y., Nair G.B., and Ramamurthy T. Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-1997 in Calcutta, India. Epidemiology and Infection 124 (2000) 393-399
16. Gorbach S.L., Banwell J.G., Chatterjee B.D., Jacobs B., and Sack R.B. Acute undifferentiated human diarrhea in the tropics. I. Alterations in intestinal microflora. Journal of Clinical Investigation 50 (1971) 881-889
17. Guidry J.J., Ca'rdenas L., Cheng E., and Clements J.D. Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin. Infection and Immunity 65 (1997) 4943-4950
18. Haustedt L.O., Mang C., Siems K., and Schiewe H. Rational approaches to natural-product-based drug design. Current Opinion in Drug Discovery & Development 9 (2006) 445-462
19. Hitotsubashi S., Fujii Y., Yamanaka H., and Okamoto K. Some properties of purified Escherichia coli heat-stable enterotoxin II. Infection and Immunity 60 (1992) 4468-4474
20. Holmgren J., and Svennerholm A.M. Bacterial enteric infections and vaccine development. Gastroenterology Clinics of North America 21 (1992) 283-302
21. Isbrucker R.A., and Burdock G.A. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regulatory Toxicology and Pharmacology: RTP 6 (2006) 167-192
22. Li S.T., Grossman D.C., and Cummings P. Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis. PLoS Medicine 4 (2007) e98
23. Merritt E.A., and Hol W.G. AB5 toxins. Current Opinion in Structural Biology 5 (1995) 165-171
24. Minke W.E., Roach C., Hol W.G., and Verlinde C.L.M.J. Structurebased exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonist. Biochemistry 38 (1999) 5684-5692
25. Mascolo N., Izzo A.A., Barbato F., and Capasso F. Inhibition of nitric oxide synthetase prevent castor-oil-induced diarrhoea in the rat. British Journal of Pharmacology 108 (1993) 861-864
26. Mascolo N., Izzo A.A., and Capasso F. Castor oil-induced diarrhoea: involvement of nitric oxide. In: Capasso F., and Mascolo N. (Eds). Natural Drugs and the Digestive Tract (1992), EMSI, Rome 123-127
27. Mitchell D.D., Pickens J.C., Korotkov K., Fan E., and Hol W.G. 3,5-Substituted phenyl galactosides as leads in designing effective cholera toxin antagonists; synthesis and crystallographic studies. Bioorganic and Medicinal Chemistry 12 (2004) 907-920
28. Pharmacopoeia Commission of People's Republic of China (ChPC). Pharmacopoeia of People's Republic of China (ChP) vol. 1 (2005), Chemical Industry Press, Beijing pp. 59-60
29. Pickens J.C., Merritt E.A., Ahn M., Verlinde C.L., Hol W.G., and Fan E. Anchor-based design of improved cholera toxin and E. coli heatlabile enterotoxin receptor binding antagonists that display multiple binding modes. Chemistry and Biology 9 (2002) 215-224
30. Pierce N.F., Carpenter C.C.J., Elliot H.Z., and Greenough W.B. Effects of prostaglandins, theophylline and Cholera exotoxin upon transmucosal water and electrolyte movement in canine jejunum. Gastroenterology 60 (1971) 22-32
31. Schüttelkopf A.W., and van Aalten D.M. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica. Section D, Biological Crystallography 60 (2004) 1355-1363
32. Shen J., Xu X., Cheng F., Liu H., Luo X., Shen J., Chen K., Zhao W., Shen X., and Jiang H. Virtual screening on natural products for discovering active compounds and target information. Current Medicinal Chemistry 10 (2003) 2327-2342
33. Sixma T.K., Kalk K.H., van Zanten B.A., Dauter Z., Kingma J., Witholt B., and Hol W.G. Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin. Journal of Molecular Biology 230 (1993) 890-918
34. Spangler B.D. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiological Reviews 56 (1992) 622-647
35. Sparg S.G., Light M.E., and van Staden J. Biological activities and distribution of plant saponins. Journal of Ethnopharmacology 94 (2004) 219-243
36. van Der H.R., Jacobs D.I., Snoeijer W., Hallard D., and Verpoorte R. The Catharanthus alkaloids: pharmacognosy and biotechnology. Current Medicinal Chemistry 11 (2004) 607-628
37. Vincken J.P., Heng L., Groot A., and de Gruppen H. Saponins, classification and occurrence in the plant kingdom. Phytochemistry 68 (2007) 275-297
38. Wang Z.Y., and Nixon D.W. Licorice and cancer. Nutrition and Cancer 39 (2001) 1-11
39. World Health Organization (WHO), 2005. http://www.who.int/vaccine_research/about/gvrf/Qadri.pdf.
40. Wright C.W. Traditional antimalarials and the development of novel antimalarial drugs. Journal of Ethnopharmacology 100 (2005) 67-71